| How can you make such an assumption with so little data? It might be that you've met people from this fund and you know something I don't, but until then your statement sounds a wee bit unqualified. It's hard to swallow that given they have invested in, > SpaceX ( http://www.youtube.com/watch?v=WTFlFFrfEB0&feature=youtu... ) > Halcyon Molecular ( http://www.genomeweb.com/sequencing/halcyon-molecular-develo... ) > Palantir > Pathway Genomics ( http://www.crunchbase.com/company/pathway-genomics ) > Gene Security Network ( http://www.crunchbase.com/company/gene-security-network ) > CDD ( http://www.crunchbase.com/company/collaborative-drug-discove... ) > ImmunePath ( www.immunepath.com/ ) > RoboTex ( http://www.robotex.us/ ) > SmartDrive ( http://www.crunchbase.com/company/smartdrive-systems ) > Navia ( http://www.crunchbase.com/company/navia-systems ) That doesn't sound like a social-mobile-local marketing companies portfolio to me, and yes I've seen their investments in companies such as Yammer, RapLeaf, but clearly they aren't their entire portfolio and they have taken a series of really impressive long term bets. |
The entire essay is bullshit.